4.7 Letter

Sequence Type ST405 Escherichia coli Isolate Producing QepA1, CTX-M-15, and RmtB from Detroit, Michigan

期刊

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 55, 期 8, 页码 3966-3967

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00652-11

关键词

-

资金

  1. NIAID NIH HHS [K22AI080584, R03AI079296, K22 AI080584, R03 AI079296] Funding Source: Medline

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Infectious Diseases

Staphylococcus lugdunensis bacteremia: clinical implications of single set positive blood cultures

Toshiharu Sasaki, Yohei Doi

Summary: This study investigated cases of S. lugdunensis bacteremia and found that the clinical significance of single-positive cases is uncertain. Among all cases, only a small subset of low-risk patients did not require antimicrobial therapy, and they had no adverse clinical consequences.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2023)

Article Infectious Diseases

Short-course remdesivir for healthcare-associated COVID-19: Case series from a non-acute care hospital

Yu Takahashi, Hideaki Wakita, Takuma Ishihara, Hideto Okazaki, Akihiro Ito, Mitsunaga Iwata, Shigeru Sonoda, Yohei Doi

Summary: Healthcare-associated COVID-19 among vulnerable patients leads to disproportionate morbidity and mortality. Early pharmacologic intervention may reduce negative sequelae and improve survival in such settings. This study aimed to describe outcome of patients with healthcare-associated COVID-19 who received early short-course remdesivir therapy.

JOURNAL OF INFECTION AND CHEMOTHERAPY (2023)

Letter Infectious Diseases

Antimicrobial susceptibility testing in clinical Mycobacterium tuberculosis isolates

Jiachen Li, Siyuan Feng, Yuhui Chen, Meiling Yu, Wenjing Wei, Guo-Bao Tian

LANCET MICROBE (2023)

Article Infectious Diseases

Impact of adherence to procalcitonin antibiotic prescribing guideline recommendations for low procalcitonin levels on antibiotic use

Brian N. Malley, Jonathan Yabes, Elizabeth H. Gimbel, Chung-Chou H. Chang, Donald A. Yealy, Michael Fine, Derek M. Angus, David T. F. Huang

Summary: The Procalcitonin Antibiotic Consensus Trial (ProACT) found that providing a procalcitonin antibiotic prescribing guideline to hospital-based clinicians did not reduce antibiotic use. The study aimed to determine the threshold adherence rate for reducing antibiotic use and to explore opportunities to increase adherence.

BMC INFECTIOUS DISEASES (2023)

Article Immunology

Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19): The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study

Hiroshi Mukae, Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, Hiroki Sakaguchi, Takuhiro Sonoyama, Genki Ichihashi, Takao Sanaki, Keiko Baba, Yuko Tsuge, Takeki Uehara

Summary: This study evaluated the efficacy and safety of ensitrelvir for mild-to-moderate COVID-19 during the Omicron epidemic. The results showed that ensitrelvir treatment significantly reduced the SARS-CoV-2 titer compared to placebo. However, there was no significant difference in the total score of the 12 COVID-19 symptoms. Overall, ensitrelvir demonstrated favorable antiviral efficacy and potential clinical benefit with an acceptable safety profile.

CLINICAL INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients

Emily L. Heil, Kimberly C. Claeys, Ellen G. Kline, Tara M. Rogers, Kevin M. Squires, Alina Iovleva, Yohei Doi, Mary Banoub, Mandee M. Noval, Paul M. Luethy, Ryan K. Shields

Summary: This study evaluated the clinical characteristics and outcomes of COVID-19 patients with CRAB infections who received three-drug combination regimens. It found that the use of three-drug regimens resulted in high rates of clinical response and low mortality in severe CRAB infections among COVID-19 patients.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Medicine, General & Internal

A phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part)

Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, Takumi Imamura, Takuhiro Sonoyama, Genki Ichihashi, Takao Sanaki, Yuko Tsuge, Takeki Uehara, Hiroshi Mukae

Summary: This study aims to evaluate the efficacy and safety of ensitrelvir in patients with mild-to-moderate COVID-19. It is a phase 3 study using a multicenter, randomized, double-blind, placebo-controlled design. The primary endpoint is the time to resolution of COVID-19 symptoms, and key secondary endpoints include the change in SARS-CoV-2 viral RNA and the time to first negative viral titer.

MEDICINE (2023)

Article Immunology

The autotransporter BafA contributes to the proangiogenic potential of Bartonella elizabethae

Natsumi Suzuki, Kayo Kumadaki, Kaoru Tatematsu, Yohei Doi, Kentaro Tsukamoto

Summary: Bartonella elizabethae is a rat-borne zoonotic bacterium that can cause human infectious endocarditis or neuroretinitis. There have been reports of bacillary angiomatosis (BA) caused by this bacterium, raising the possibility that B. elizabethae may also induce vasoproliferation. However, the effects of this bacterium on human vascular endothelial cells (ECs) are still unknown.

MICROBIOLOGY AND IMMUNOLOGY (2023)

Article Microbiology

A compensatory RNase E variation increases Iron Piracy and Virulence in multidrug-resistant Pseudomonas aeruginosa during Macrophage infection

Mylene Vaillancourt, Anna Clara Milesi Galdino, Sam P. Limsuwannarot, Diana Celedonio, Elizabeth Dimitrova, Matthew Broerman, Catherine Bresee, Yohei Doi, Janet S. Lee, William C. Parks, Peter Jorth

Summary: This study investigates the virulence mechanisms of antibiotic resistant Pseudomonas aeruginosa in cystic fibrosis (CF) patients. It reveals that a mutation in the RNase E gene leads to increased production of siderophores, which damage macrophage cell membranes and cause cell death. The study also suggests that gallium can reduce the virulence of RNase E variants and may serve as a precision therapy for these infections.

PLOS PATHOGENS (2023)

Article Immunology

Phagocytosis is a primary determinant of pulmonary clearance of clinical Klebsiella pneumoniae isolates

Rick van der Geest, Hongye Fan, Hernan F. Penaloza, William G. Bain, Zeyu Xiong, Naina Kohli, Emily Larson, Mara L. G. Sullivan, Jonathan M. Franks, Donna B. Stolz, Ryota Ito, Kong Chen, Yohei Doi, Melanie J. Harriff, Janet S. Lee

Summary: This study found heterogeneity in the sensitivity of clinical Kp isolates to macrophage phagocytic uptake, and demonstrated that phagocytosis is a significant determinant of the pathogenicity of Kp in the lungs.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2023)

Article Microbiology

Carbonic Anhydrase Inhibition as a Target for Antibiotic Synergy in Enterococci

Gayatri Shankar Chilambi, Yu-Hao Wang, Nathan R. Wallace, Chetachukwu Obiwuma, Kirsten M. Evans, Yanhong Li, Menna-Allah W. Shalaby, Daniel P. Flaherty, Ryan K. Shields, Yohei Doi, Daria Van Tyne

Summary: This study identified a mutant strain of Enterococcus faecalis that is hypersusceptible to aminoglycoside antibiotics due to disruption of alpha-carbonic anhydrase (alpha-CA). Disruption of alpha-CA increased proton motive force and membrane permeability, leading to increased gentamicin uptake in E. faecalis. Additionally, an FDA-approved alpha-CA inhibitor sensitized various E. faecalis strains to gentamicin.

MICROBIOLOGY SPECTRUM (2023)

Article Microbiology

Daily fosfomycin versus levofloxacin for complicated urinary tract infections

Nadine Rouphael, Patricia Winokur, Michael C. Keefer, Jessica Traenkner, Ana Drobeniuc, Yohei Doi, Sonal Munsiff, Vance G. Fowler, Scott Evans, Randolph E. Oler, Bonifride Tuyishimire, Marina Lee, Varduhi Ghazaryan, Henry F. Chambers

Summary: Concerns over resistance and safety have been identified in the current treatment regimen for complicated urinary tract infections. Fosfomycin is a drug that is routinely used for the treatment of uncomplicated cystitis. This study shows that fosfomycin could be an oral alternative as step-down therapy for the treatment of complicated urinary tract infections, with a clinical cure rate comparable to levofloxacin but a lower microbiological success rate 3 weeks from start of antibiotics.
Article Engineering, Biomedical

Arginine-Enhanced Antimicrobial Activity of Nanozymes against Gram-Negative Bacteria

Zihan Zhao, Shu'an Wen, Ningning Song, Lixiang Wang, Yuan Zhou, Xue Deng, Changbu Wu, Guili Zhang, Jun Chen, Guo-Bao Tian, Minmin Liang, Lan-Lan Zhong

Summary: This study demonstrates that combining antimicrobial nanozymes with L-arginine can effectively treat difficult-to-treat Gram-negative pathogen infections. The combination treatment enhances bacterial membrane permeability and promotes ROS production, leading to the killing of pathogens.

ADVANCED HEALTHCARE MATERIALS (2023)

Article Microbiology

Genomic epidemiology and antibiotic susceptibility profiling of uropathogenic Escherichia coli among children in the United States

Rauf Salamzade, Christi L. McElheny, Abigail L. Manson, Ashlee M. Earl, Nader Shaikh, Yohei Doi

Summary: Escherichia coli is the most common cause of urinary tract infections (UTIs) in children. However, the mechanisms of virulence and antibiotic resistance, as well as the population structure of this species, are poorly understood in this age group. This study examined the genetic markers and population structure of uropathogenic E. coli (UPEC) in children with UTIs. The results revealed similarities between UPEC populations in children and adults, with certain genetic markers being more common in pediatric pyelonephritis cases. Additionally, antibiotic resistance was correlated with known genetic markers, and a fimbrial gene allele was found to confer a selective advantage for UPEC.

MSPHERE (2023)

Article Microbiology

Comparison of three rapid diagnostic tests for bloodstream infections using Benefit-risk Evaluation Framework (BED-FRAME)

Richard D. Smith, Min Zhan, Shanshan Zhang, Surbhi Leekha, Anthony Harris, Yohei Doi, Scott Evans, J. Kristie Johnson, Robert K. Ernst

Summary: This study evaluated a new rapid lipid analysis technique called FLAT MS for direct identification of pathogens from blood cultures. FLAT MS showed slight differences in accuracy compared to other FDA-approved methods for identifying Gram-positive bacteria, Gram-negative bacteria, and yeast. The time-to-results and hands-on time of FLAT MS were comparable to other methods.

JOURNAL OF CLINICAL MICROBIOLOGY (2023)

暂无数据